CClinicalTrials.gg
CompletedNCT00996632UKBCUpdated Nov 11, 2009Results posted

The Use of a High-frequency Ultrasonic Knife in Breast Cancer Surgery

An interventional study of ultrasonic knife (Ultracision®, Ethicon Endo Surgery) and conventional diarthermy knife in Breast Cancer, sponsored by University of Trieste. Completed at 1 site in Italy. Open to participants aged 36 Years to 95 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2009-11-11.

Sponsored by University of Trieste · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
94
Allocation
Randomized
Ages
36 Years to 95 Years
Sex
All
01

Study summary

Background: Lymphatic stasis and seroma formation are common complications of axillary lymphadenectomy in breast cancer surgery. The investigators aim is to test the hypothesis that the use of an ultrasonic knife for axillary dissection reduces the total amount and duration of persistent drainage and length of hospital stay. Method: The investigators have conducted a randomized trial on 94 patients (1 male, 93 females, mean age 64.7 years) who presented to the investigators unit with operable breast carcinoma. Patients in group A (38 cases) were operated on using exclusively the ultrasonic knife. Patients in group B (56 cases) were operated on using the conventional diathermy knife.

Read the detailed description

The ultrasonic knife we have used in our study exploits the electrical impulses produced by a high-frequency ultrasound generator, transferred to a hand piece and converted into a mechanical movement at a frequency of 55.5 kHz (11,12) (Ultracision®, Ethicon Endo Surgery ). We have chosen this instrument because the relatively low temperatures generated in the process, ranging from 50 to 100 °C, result in a coagulative necrosis which allows both cutting and effective sealing of blood and lymphatic vessels, therefore preventing lymphatic leaks more effectively compared with conventional diathermy. The latter produces temperature up to 400 °C resulting in char formation and deleterious thermal effects to a distance of up to 1cm from the blade and extensive formation of necrotic tissue.

We have estimated Using the data of a previous unpublished pilot study, the sample size required for our trial using the data of a previous unpublished pilot study, indicating that to detect a significant difference in length of stay (delta = 4of four days, with a mean standard deviationsdigma of = 4.5 days, between the two groups with a level of significance of alpha = 5% and a power of1 - beta = 90%), we needed to enroll was estimated in 28 patients in each group arm. As a precaution we decided to increase the sample size by 25% to 35 patients per group arm, in case we needed to use non-parametric tests in subsequent statistical analysis. A total of 94 patients with operable breast carcinoma were recruited between January 2000 and December 2004: 1 male and 93 females (min 34, q1 58, median 65, mean 64.7, q3 73, max 95). All patients underwent total mastectomy or quadrantectomy and 1st or 2nd level axillary lymphadenectomy. Patients were randomly allocated to two treatment groups: patients allocated to Group A were operated on using exclusively the ultrasonic knife (Ultracision®, Ethicon Endo Surgery) for both the mastectomy or quadrantectomy and axillary dissection (38 cases, mean age of 64.6 years, min 34, q1 58, median 66, q3 70, max 95); patients allocated to Group B (control group) were operated on using a conventional diarthermy knife was (56 cases, mean age of 65.0 years,min 37, q1 59, median 65, q3 74, max 89). In all cases the type of a redon n°14 suction drain was left in the axillary cavity and removed as soon as the amount of fluid dropped to 35 ml/24h or less. The patient was discharged home the same day the drain was removed.

During the postoperative period the following data were collected: the total amount of fluid drained, the number of days the drain was leftof drainage, the length of post-operative stay, and early and late complications. Early complications were specifically recorded: wound seromas and hematomas, wound infections, necrosis of wound margins and period of time (in days) the seroma needed to be needle-aspirated following removal of the drain. Late complications recorded were lymphedema, strength and sensation deficits and chronic arm pain. A cost analysis was also done considering materials employed and length of hospital stay. Statistical analysis was done using open source "R" software, version 2.5.1 (18). The Shapiro-Wilk test was used to verify the normal distribution of data; heteroscedastic, normally distributed data were analysed using the F-test of variance; Student's t test was used for homoscedastic data. For non normally distributed data the non-parametric Wilcoxon-Mann-Whitney test was used. Survival analysis was analysed using Cox's regression model, in the hypothesis of proportional risk.

02

Conditions studied

  • Breast Cancer

Browse trials for

Keywords

  • breast cancer
  • ultrasonic knife
  • volume drainage
03

In context

Breast Neoplasms

12,544 studies on the registry are indexed under Breast Neoplasms; 2,892 are open to participants now.

This study's enrollment of 94 is above the median of 72 across 9,303 interventional studies indexed under Breast Neoplasms.

Browse Breast Neoplasms studies →

Lead sponsor

University of Trieste is the lead sponsor of 39 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
36 Years to 95 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Operable breast cancer

Exclusion criteria

Exclusion Criteria:

  • Inoperable breast cancer
  • BMI > 25
  • Neoadiuvant radioterapy
  • Carcinomastitis
  • Previous phlebitis of omolateral arm
  • Collagen disease
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
94 participants (actual)

Study arms

  • Experimental
    A

    Patients were operated using an ultrasonic knife (Ultracision®, Ethicon Endo Surgery)

    Procedure: ultrasonic knife (Ultracision®, Ethicon Endo Surgery)

  • Active comparator
    B

    Patients were operated using a conventional diarthermy knife

    Procedure: conventional diarthermy knife

Interventions

  • Procedureultrasonic knife (Ultracision®, Ethicon Endo Surgery)

    mastectomy or quadrantectomy and axillary dissection by an ultrasonic knife (Ultracision®, Ethicon Endo Surgery)

  • Procedureconventional diarthermy knife

    mastectomy or quadrantectomy and axillary dissection using conventional diarthermy knife

06

What researchers measure

Primary outcomes

  1. Drainage Volume

    volume in milliliters of axillary drainage

    Time frame: discharge day

Secondary outcomes

  1. Time of Discharge

    evaluation about the time of discharge from hospital

    Time frame: days

07

Results

Posted Oct 16, 2009

Participant flow

Patients affected by Breast Cancer

Participant flow — Overall Study
MilestoneUltrasonicConventional
Started3856
Completed3856
Not completed00
Withdrew: Physician decision00

Outcome measures

PrimaryDrainage Volume

volume in milliliters of axillary drainage

Time frame:
discharge day
Reported as:
Mean · milliliters
Drainage Volume
millilitersUltrasonicConventional
Drainage Volume182.6 ± 267.1525.2 ± 629.0
Statistical analysis
  • Ultrasonic vs Conventional · Wilcoxon (Mann-Whitney) · p = <0.05
SecondaryTime of Discharge

evaluation about the time of discharge from hospital

Time frame:
days
Reported as:
Mean · Days
Time of Discharge
DaysUltrasonicConventional
Time of Discharge4.5 ± 2.18.1 ± 5.1
Statistical analysis
  • Ultrasonic vs Conventional · Wilcoxon (Mann-Whitney) · p = 0.05

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Ultrasonic———
Conventional———

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)UltrasonicConventionalTotal
<=18 years000
Between 18 and 65 years192645
>=65 years193049
Age Continuous
Age Continuous(years)UltrasonicConventionalTotal
Mean64.6 ± 12.365.0 ± 12.564.7 ± 12.4
Sex: Female, Male
Sex: Female, Male(Participants)UltrasonicConventionalTotal
Female375693
Male101
Region of Enrollment
Region of Enrollment(participants)UltrasonicConventionalTotal
Italy385694
08

Study locations

1 site
  • University of Trieste
    Trieste, 34100, Italy
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 11, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00996632
Lead sponsor
University of Trieste
First posted
Oct 16, 2009
Start date
Sep 2000
Primary completion
Sep 2004
Completion
Nov 2004
Results posted
Oct 16, 2009
Last update
Nov 11, 2009

Study contacts

Nicolò de Manzini, Professor
principal investigator · University of Trieste

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion